Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Mayo Clinic
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine